{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:52:57Z","timestamp":1791359577606,"version":"4.3.1"},"reference-count":53,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Fabry disease (FD) is a rare X-linked lysosomal storage disorder characterized by the progressive accumulation of globotriaosylceramide in multiple organs. Despite the availability of disease-specific therapies, diagnosis is often delayed due to heterogeneous and nonspecific manifestations. This review aimed to synthesize current evidence on dermatological manifestations of FD and their potential contribution to earlier disease recognition. A scoping review was conducted following the Arksey and O'Malley framework and the PRISMA-ScR guidelines. PubMed, Scopus, and Web of Science were searched for relevant studies, and additional records were identified through snowballing of reference lists from retrieved reviews. Thirty-two records were included, comprising data on 2,209 patients, with detailed patient-level information available for 146 individuals. Dermatologists were involved in the diagnostic process in 66% of the included studies, and 69% of these reported a potential contribution of dermatological evaluation to earlier disease recognition. Angiokeratomas (88% of included studies) and hypohidrosis (50% of included studies) were the most frequently reported cutaneous manifestations. Skin biopsy or histopathological examination was reported in 59% of included studies and was the most frequently reported dermatological investigative technique. Among patients with dermatological manifestations and available diagnostic delay information, 66% had a reported diagnostic delay of 1\u201310 years. These findings suggest that dermatological manifestations may contribute to earlier recognition of FD. However, they should be interpreted cautiously given the descriptive nature of the available evidence, the absence of an appropriate comparator group, and the potential influence of selection and publication bias.<\/jats:p>","DOI":"10.3389\/fmed.2026.1899166","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:27:36Z","timestamp":1791358056000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["The role of dermatological manifestations in the early diagnosis of Fabry disease: a scoping review"],"prefix":"10.3389","volume":"13","author":[{"given":"Alessandra","family":"Maio","sequence":"first","affiliation":[{"name":"University Department of Life Science and Public Health, Section of Hygiene, Universit\u00e0 Cattolica del Sacro Cuore","place":["Rome, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo Linda Maria","family":"Sinagra","sequence":"additional","affiliation":[{"name":"CEDRI, Istituto Dermopatico dell'Immacolata IDI-IRCCS","place":["Rome, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Pascolini","sequence":"additional","affiliation":[{"name":"Genetic Counseling Unit, Istituto Dermopatico dell'Immacolata IDI-IRCCS","place":["Rome, Italy"]},{"name":"Rare Skin Diseases Center, Istituto Dermopatico dell'Immacolata (IDI)-IRCCS","place":["Rome, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerardo","family":"Altamura","sequence":"additional","affiliation":[{"name":"Hospital Management, Istituto Dermopatico dell\u2019Immacolata, IDI-IRCCS","place":["Rome, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Di Zenzo","sequence":"additional","affiliation":[{"name":"Molecular and Cell Biology Laboratory, Istituto Dermopatico dell'Immacolata, IDI-IRCCS","place":["Rome, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annarita","family":"Panebianco","sequence":"additional","affiliation":[{"name":"Hospital Management, Istituto Dermopatico dell\u2019Immacolata, IDI-IRCCS","place":["Rome, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,10,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/j.chest.2017.12.018","article-title":"The challenge of rare diseases","volume":"153","author":"Stoller","year":"2018","journal-title":"Chest"},{"key":"B2","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1007\/s11606-014-2881-2","article-title":"Important role of translational science in rare disease innovation, discovery, and drug development","volume":"29","author":"Pariser","year":"2014","journal-title":"J Gen Intern Med"},{"key":"B3","year":""},{"key":"B4","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.amjms.2020.07.011","article-title":"When and how to diagnose Fabry disease in clinical practice","volume":"360","author":"Michaud","year":"2020","journal-title":"Am J Med Sci"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1016\/S0140-6736(08)61589-5","article-title":"Fabry\u2019s disease","volume":"372","author":"Zarate","year":"2008","journal-title":"Lancet"},{"key":"B6","doi-asserted-by":"publisher","first-page":"440","DOI":"10.3238\/arztebl.2009.0440","article-title":"Fabry disease\u2014often seen, rarely diagnosed","volume":"106","author":"Hoffmann","year":"2009","journal-title":"Dtsch Arztebl Int"},{"key":"B7","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.ymgme.2020.04.006","article-title":"A comprehensive testing algorithm for the diagnosis of Fabry disease in males and females","volume":"130","author":"Stiles","year":"2020","journal-title":"Mol Genet Metab"},{"key":"B8","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1080\/1364557032000119616","article-title":"Scoping studies: towards a methodological framework","volume":"8","author":"Arksey","year":"2005","journal-title":"Int J Soc Res Methodol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/j.0954-6820.1982.tb01952.x","article-title":"Clinical and diagnostic considerations in Fabry\u2019s disease","volume":"211","author":"Ahlm\u00e9n","year":"1982","journal-title":"Acta Med Scand"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.3390\/diagnostics13142368","article-title":"A cross-sectional study of the dermatological manifestations of patients with Fabry disease and the assessment of angiokeratomas with multimodal imaging","volume":"13","author":"Anker","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"B11","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1111\/j.1525-1470.2005.22411.x","article-title":"Fabry disease: an atypical presentation","volume":"22","author":"Choudhury","year":"2005","journal-title":"Pediatr Dermatol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.5070\/D35bk233zq","article-title":"A family with Fabry disease diagnosed by a single angiokeratoma","volume":"17","author":"Corry","year":"2011","journal-title":"Dermatol Online J"},{"key":"B13","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1590\/abd1806-4841.20142785","article-title":"Fabry disease: clinical and genotypic aspects of three cases in first degree relatives","volume":"89","author":"Da Silva","year":"2014","journal-title":"An Bras Dermatol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1111\/j.1365-2133.1970.tb06828.x","article-title":"Fabry\u2019s disease in children","volume":"82","author":"De Groot","year":"1970","journal-title":"Br J Dermatol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1590\/abd1806-4841.20187128","article-title":"Genital angiokeratoma in a woman with Fabry disease: the dermatologist\u2019s role","volume":"93","author":"De Jesus","year":"2018","journal-title":"An Bras Dermatol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1314.e1","DOI":"10.1016\/j.avsg.2013.09.009","article-title":"An unusual case of familial lymphedema","volume":"28","author":"Dean","year":"2014","journal-title":"Ann Vasc Surg"},{"key":"B17","doi-asserted-by":"publisher","first-page":"319","DOI":"10.2340\/0001555549319325","article-title":"Angiokeratoma corporis diffusum (Fabry\u2019s disease)","volume":"49","author":"Dilorenzo","year":"1969","journal-title":"Acta Derm Venereol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.neurol.2017.05.007","article-title":"Peripheral nerve involvement in Fabry\u2019s disease: which investigations? A case series and review of the literature","volume":"173","author":"Franques","year":"2017","journal-title":"Rev Neurol (Paris)"},{"key":"B19","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.ymgme.2013.07.005","article-title":"Enzyme replacement therapy in two Japanese siblings with Fabry disease, and its effectiveness on angiokeratoma and neuropathic pain","volume":"110","author":"Furujo","year":"2013","journal-title":"Mol Genet Metab"},{"key":"B20","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1046\/j.1445-5994.2002.00291.x","article-title":"Clinical features of Fabry\u2019s disease in Australian patients","volume":"32","author":"Galanos","year":"2002","journal-title":"Intern Med J"},{"key":"B21","doi-asserted-by":"publisher","first-page":"235","DOI":"10.4103\/ds.ds_15_19","article-title":"Hypohidrosis as a clue to the early diagnosis of Fabry disease and prevention of late complications","volume":"37","author":"Hsu","year":"2019","journal-title":"Dermatol Sin"},{"key":"B22","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1111\/ced.12501","article-title":"Hypohidrosis: an early clue in the diagnosis of Fabry disease","volume":"40","author":"Jung","year":"2015","journal-title":"Clin Exp Dermatol"},{"key":"B23","first-page":"15","article-title":"Fabry disease: a case report","volume":"14","author":"Kotnik","year":"2005","journal-title":"Acta Dermatovenerol Alp Pannonica Adriat"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1001\/archderm.140.12.1440","article-title":"Fabry disease: a study of 6 hemizygous men and 5 heterozygous women with emphasis on dermatologic manifestations","volume":"140","author":"Larralde","year":"2004","journal-title":"Arch Dermatol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1084336","DOI":"10.3389\/fped.2023.1084336","article-title":"Clinical features and enzyme replacement therapy in 10 children with Fabry disease","volume":"11","author":"Li","year":"2023","journal-title":"Front Pediatr"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1111\/j.1742-1241.2006.01061.x","article-title":"Hyperhidrosis: a new and often early symptom in Fabry disease. International experience and data from the Fabry outcome survey","volume":"60","author":"Lidove","year":"2006","journal-title":"Int J Clin Pract"},{"key":"B27","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1111\/j.1399-0004.2011.01718.x","article-title":"Fabry disease \u201cthe new great imposter\u201d: results of the French observatoire in internal medicine departments (FIMeD)","volume":"81","author":"Lidove","year":"2012","journal-title":"Clin Genet"},{"key":"B28","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/BF03040321","article-title":"Anderson-Fabry disease in Austria","volume":"115","author":"Lorenz","year":"2003","journal-title":"Wien Klin Wochenschr"},{"key":"B29","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.jpeds.2010.02.012","article-title":"Misdiagnosis in Fabry disease","volume":"156","author":"Marchesoni","year":"2010","journal-title":"J Pediatr"},{"key":"B30","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/j.1440-0960.2007.00326.x","article-title":"Fabry disease in a heterozygote presenting as hand ischaemia and painful acroparaesthesia","volume":"48","author":"Martin","year":"2007","journal-title":"Australas J Dermatol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1111\/j.1365-2362.2004.01309.x","article-title":"Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry outcome survey","volume":"34","author":"Mehta","year":"2004","journal-title":"Eur J Clin Invest"},{"key":"B32","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1001\/archneur.56.4.487","article-title":"The cutaneous stigmata of Fabry disease: an X-linked phakomatosis associated with central and peripheral nervous system dysfunction","volume":"56","author":"Menkes","year":"1999","journal-title":"Arch Neurol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"156","DOI":"10.17826\/cutf.47675","article-title":"Fabry disease: a turkish case with a novel mutation and dermatological manifestations","volume":"40","author":"Mungan","year":"2015","journal-title":"Cukurova Med J"},{"key":"B34","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1111\/1346-8138.16237","article-title":"Beneficial screening of Fabry disease in patients with hypohidrosis","volume":"49","author":"Nagai-Sangawa","year":"2022","journal-title":"J Dermatol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1007\/BF01540061","article-title":"Anorexia, weight loss, and diarrhea as presenting symptoms of angiokeratoma corporis diffusum (Fabry\u2013Anderson disease)","volume":"34","author":"Nelis","year":"1989","journal-title":"Dig Dis Sci"},{"key":"B36","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/j.1365-2133.2007.08002.x","article-title":"Fabry disease and the skin: data from FOS, the Fabry outcome survey","volume":"157","author":"Orteu","year":"2007","journal-title":"Br J Dermatol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s00431-003-1299-3","article-title":"The early clinical phenotype of Fabry disease: a study on 35 European children and adolescents","volume":"162","author":"Ries","year":"2003","journal-title":"Eur J Pediatr"},{"key":"B38","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.clinph.2019.01.008","article-title":"Dyshidrosis is associated with reduced amplitudes in electrically evoked pain-related potentials in women with Fabry disease","volume":"130","author":"Siedler","year":"2019","journal-title":"Clin Neurophysiol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"471","DOI":"10.2340\/00015555-1497","article-title":"Electron microscopy of cherry haemangioma in the early diagnosis of Fabry disease","volume":"93","author":"Tokuriki","year":"2013","journal-title":"Acta Derm Venereol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1001\/archderm.131.1.82","article-title":"Punctate and linear angiectases. Anderson-Fabry disease (angiokeratoma corporis diffusum)","volume":"131","author":"Werninghaus","year":"1995","journal-title":"Arch Dermatol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s40259-025-00723-3","article-title":"Progress and challenges in the treatment of Fabry disease","volume":"39","author":"Lenders","year":"2025","journal-title":"BioDrugs"},{"key":"B42","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.ymgme.2021.12.004","article-title":"Early start of enzyme replacement therapy in pediatric male patients with classical Fabry disease is associated with attenuated disease progression","volume":"135","author":"van Der Veen","year":"2022","journal-title":"Mol Genet Metab"},{"key":"B43","doi-asserted-by":"publisher","first-page":"189","DOI":"10.2165\/00128071-200304030-00005","article-title":"Fabry disease: recognition and management of cutaneous manifestations","volume":"4","author":"M\u00f6hrenschlager","year":"2003","journal-title":"Am J Clin Dermatol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1111\/j.1365-2133.2012.10742.x","article-title":"Angiokeratoma: decision-making aid for the diagnosis of Fabry disease","volume":"166","author":"Zampetti","year":"2012","journal-title":"Br J Dermatol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1111\/1346-8138.17690","article-title":"Cutaneous manifestations of Fabry disease: a systematic review","volume":"52","author":"Al-Chaer","year":"2025","journal-title":"J Dermatol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1111\/j.1365-2230.2009.03721.x","article-title":"Angiokeratoma: a cutaneous marker of Fabry\u2019s disease","volume":"35","author":"Albano","year":"2010","journal-title":"Clin Exp Dermatol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"6031","DOI":"10.2174\/13816128113199990359","article-title":"Cutaneous complications of anderson-Fabry disease","volume":"19","author":"Giuseppe","year":"2013","journal-title":"Curr Pharm Des"},{"key":"B48","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1007\/s10545-007-0521-2","article-title":"Fabry disease: baseline medical characteristics of a cohort of 1765 males and females in the Fabry registry","volume":"30","author":"Eng","year":"2007","journal-title":"J Inherit Metab Dis"},{"key":"B49","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.gene.2017.10.064","article-title":"Female Fabry disease patients and X-chromosome inactivation","volume":"641","author":"Juchniewicz","year":"2018","journal-title":"Gene"},{"key":"B50","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1001\/jama.281.3.249","article-title":"Prevalence of lysosomal storage disorders","volume":"281","author":"Meikle","year":"1999","journal-title":"JAMA"},{"key":"B51","year":""},{"key":"B52","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1086\/504601","article-title":"High incidence of later-onset Fabry disease revealed by newborn screening","volume":"79","author":"Spada","year":"2006","journal-title":"Am J Hum Genet"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1002\/humu.21074","article-title":"Newborn screening for Fabry disease in Taiwan reveals a high incidence of the later-onset GLA mutation c.936+919G>A (IVS4+919G>A)","volume":"30","author":"Hwu","year":"2009","journal-title":"Hum Mutat"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1899166\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:27:37Z","timestamp":1791358057000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1899166\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,6]]},"references-count":53,"alternative-id":["10.3389\/fmed.2026.1899166"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1899166","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,6]]},"article-number":"1899166"}}